Hayashi K, Yokose T, Lancey J, et al. Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of tolerance. Research square. 2025. doi:10.21203/rs.3.rs-7236564/v1
Publications
Schweickart A, Peng C, Zeleznik O, et al. Metabolomic signatures of hypocaloric dietary interventions associate with breast cancer risk in the Nurses’ Health Study II. medRxiv : the preprint server for health sciences. 2025. doi:10.1101/2025.08.18.25333805
Qiu T, Zhuang Z, Byun WS, et al. Development of Degraders and 2-pyridinecarboxyaldehyde (2-PCA) as a recruitment Ligand for FBXO22. bioRxiv : the preprint server for biology. 2025. doi:10.1101/2025.08.19.671158
Bueckle A, Herr BW, Chen L, et al. Constructing and Using Cell Type Populations of the Human Reference Atlas. bioRxiv : the preprint server for biology. 2025. doi:10.1101/2025.08.14.670406
Liu T, Zhang X, Lin J, Pinello L, Ying R, Zhao H. Pre-training Genomic Language Model with Variants for Better Modeling Functional Genomics. bioRxiv : the preprint server for biology. 2025. doi:10.1101/2025.02.26.640468
Mantena S, Akbari A, Raychaudhuri S. TCR germline diversity reveals evidence of natural selection on variable and joining alpha chain genes. bioRxiv : the preprint server for biology. 2025. doi:10.1101/2025.08.20.671277
Babb L, Bult C, Carey VJ, et al. Improving the FAIRness and Sustainability of the NHGRI Resources Ecosystem. ArXiv. 2025.
Ibrahim S, D’Amico D, Zhang L, et al. Navigating the life stage after stroke: From Life 2.0 to stroke prevention models of care - A qualitative exploration of younger and middle-aged adult stroke patients’ experiences and recommendations. Qualitative research in medicine & healthcare. 2025;9(2):100017. doi:10.1016/j.qrmh.2025.100017
Kraft J, Buspavanich P, Braun A, et al. Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression. JAMA psychiatry. 2025. doi:10.1001/jamapsychiatry.2025.2039
McAndrews KM, Paradiso F, Stalnecker CA, et al. An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer. Science translational medicine. 2025;17(814):eadt5511. doi:10.1126/scitranslmed.adt5511